Diagnosis of HBV-related HCC typically involves a combination of blood tests, imaging studies (such as ultrasound, CT scans, and MRI), and liver biopsy. Blood tests may include measuring levels of alpha-fetoprotein (AFP), a marker that is often elevated in liver cancer. Imaging studies help visualize tumors, while a biopsy provides a definitive diagnosis by examining liver tissue under a microscope.
